Splenic abnormalities usually present as a focal lesion(s) or diffuse splenomegaly outside the context of trauma. Most ...
Otherwise, it would lead to diseases like acute (sudden) hepatitis (inflammation), chronic (long duration) hepatitis, fatty ...
The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic ...
A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
Gurgaon: A recent study in NCR examined 150 obese adolescents aged between 10 and 18 years from January last year and found ...
Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025Denifanstat received Breakthrough Therapy ...
Globally, more than 30% of the adult population has metabolic dysfunction-associated steatotic liver disease (MASLD). People ...
Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received Breakthrough Therapy designation from FDA for MASH Clearance of Investigation ...
The number one unmet need is that we don't have a good handle on who's at risk, because patients generally don't have too ...
The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause of liver-related complications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback